James W. Purcell

800 total citations
18 papers, 591 citations indexed

About

James W. Purcell is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James W. Purcell has authored 18 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James W. Purcell's work include Sarcoma Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). James W. Purcell is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), HER2/EGFR in Cancer Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). James W. Purcell collaborates with scholars based in United States, France and Hong Kong. James W. Purcell's co-authors include Katherine Rogers, Marion P. Boland, Patrick G. Johnston, Debra T. Chao, Melvin Fox, Mien Sho, Lisa Durkin, Susan E. Morgan-Lappe, Joann P. Palma and Tamar Uziel and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

James W. Purcell

18 papers receiving 587 citations

Peers

James W. Purcell

ONCOL

IMMUN

PRM

Guo‐Kai Feng China

Diana Spiegelberg Sweden

Eleni Venetsanakos United States

Shannon Decker United States

Erich Weber Switzerland

Elisabeth Walsby United Kingdom

Oriana E. Hawkins United States

Marie-Christine Multon France

Marina Chan United States

Chi‐Ping Day United States

Guo‐Kai Feng China

James W. Purcell

241 ×0.8

ONCOL

355 ×1.3

162 ×1.3

IMMUN

56 ×0.7

PRM

138 ×1.7

Citations per year, relative to James W. Purcell James W. Purcell (= 1×) peers Guo‐Kai Feng

Countries citing papers authored by James W. Purcell

Since Specialization

Citations

This map shows the geographic impact of James W. Purcell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Purcell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Purcell more than expected).

Fields of papers citing papers by James W. Purcell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Purcell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Purcell. The network helps show where James W. Purcell may publish in the future.

Co-authorship network of co-authors of James W. Purcell

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Purcell. A scholar is included among the top collaborators of James W. Purcell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Purcell. James W. Purcell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ray, Upasana, et al.. (2022). Exploiting LRRC15 as a Novel Therapeutic Target in Cancer. Cancer Research. 82(9). 1675–1681. 31 indexed citations

Wong, Tin Lok, Lei Zhou, Kwan Man, et al.. (2022). Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling. Cellular and Molecular Gastroenterology and Hepatology. 15(1). 13–37. 17 indexed citations

Demetri, George D., Jason J. Luke, Antoine Hollebecque, et al.. (2021). First-in-Human Phase I Study of ABBV-085, an Antibody–Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors. Clinical Cancer Research. 27(13). 3556–3566. 41 indexed citations

Korai, Masaaki, James W. Purcell, Yoshinobu Kamio, et al.. (2021). Neutrophil Extracellular Traps Promote the Development of Intracranial Aneurysm Rupture. Hypertension. 77(6). 2084–2093. 38 indexed citations

Yokosuka, Kimihiko, Yoshinobu Kamio, Atsushi Kuwabara, et al.. (2021). Roles of Phytoestrogen in the Pathophysiology of Intracranial Aneurysm. Stroke. 52(8). 2661–2670. 12 indexed citations

Nicolaou, K. C., Sanjay Kumar, Ananda Rao Podilapu, et al.. (2021). Design, Synthesis, and Biological Investigation of Thailanstatin A and Spliceostatin D Analogues Containing Tetrahydropyran, Tetrahydrooxazine, and Fluorinated Structural Motifs. The Journal of Organic Chemistry. 86(3). 2499–2521. 4 indexed citations

Holte, Dane, Joseph P. Lyssikatos, Joseph Sandoval, et al.. (2020). Evaluation of PNU-159682 antibody drug conjugates (ADCs). Bioorganic & Medicinal Chemistry Letters. 30(24). 127640–127640. 15 indexed citations

Ben‐Ami, Eytan, Raul Perret, Ying Huang, et al.. (2020). LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications. Cancers. 12(3). 757–757. 19 indexed citations

Mukherjee, Sanjit, et al.. (2020). LRRC15 antibody‐drug conjugates show promise as osteosarcoma therapeutics in preclinical studies. Pediatric Blood & Cancer. 68(2). e28771–e28771. 14 indexed citations

10.

Nicolaou, K. C., Parthasarathi Subramanian, Balu D. Dherange, et al.. (2020). Streamlined Symmetrical Total Synthesis of Disorazole B₁ and Design, Synthesis, and Biological Investigation of Disorazole Analogues. Journal of the American Chemical Society. 142(36). 15476–15487. 12 indexed citations

11.

Demetri, George D., Jason J. Luke, Antoine Hollebecque, et al.. (2019). First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors.. Journal of Clinical Oncology. 37(15_suppl). 3004–3004. 12 indexed citations

12.

Purcell, James W., Jonathan A. Hickson, Melvin Fox, et al.. (2018). LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates. Cancer Research. 78(14). 4059–4072. 136 indexed citations

13.

Ben‐Ami, Eytan, Ying Huang, Prafulla C. Gokhale, et al.. (2018). Abstract 953: LRRC15 is a novel antigen in sarcoma and the therapeutic target of the antibody-drug conjugate (ADC) ABBV-085. Cancer Research. 78(13_Supplement). 953–953. 4 indexed citations

14.

Purcell, James W., Melvin Fox, Peter Lambert, et al.. (2014). Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR. Frontiers in Immunology. 4. 505–505. 12 indexed citations

15.

Purcell, James W., Mamatha Reddy, Hung Quoc Vo, et al.. (2010). Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast Cancer. Clinical Cancer Research. 16(2). 566–576. 83 indexed citations

16.

Gilbert, Jennifer L., James W. Purcell, Pádraig Strappe, et al.. (2008). Comparative evaluation of viral, nonviral and physical methods of gene delivery to normal and transformed lung epithelial cells. Anti-Cancer Drugs. 19(8). 783–788. 11 indexed citations

17.

Buckley, Niamh E., Alison M. Hosey, Julia J. Gorski, et al.. (2007). BRCA1 Regulates IFN-γ Signaling through a Mechanism Involving the Type I IFNs. Molecular Cancer Research. 5(3). 261–270. 45 indexed citations

18.

Rogers, Katherine, et al.. (2004). STAT1. Cancer Research. 64(22). 8357–8364. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact